VivoSim Labs (VIVS) Interest & Investment Income (2012 - 2026)
VivoSim Labs (VIVS) posted quarterly Interest & Investment Income of $36000.0 for Q1 2026, down 74.29% year-over-year from $140000.0 in Q1 2025, and down 60.87% quarter-over-quarter from $92000.0 in Q3 2025.
VivoSim Labs (VIVS) Interest & Investment Income (2012 - 2026) Analysis & Trends
VivoSim Labs' Interest & Investment Income history runs 15 years deep, the most recent figure standing at $36000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 74.29% year-over-year to $36000.0; the TTM figure through Mar 2026 stood at $204000.0 (down 3.32% YoY), while the FY2026 annual figure was $267000.0, up 90.71% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $36000.0, down from $92000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $451000.0 in Q1 2023, with the low at $1000.0 in Q3 2024.
- The 5-year median for Interest & Investment Income is $76000.0 (2023), against an average of $120133.3.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income jumped 22450.0% in 2023, then plunged 99.17% in 2024.
- VivoSim Labs' Interest & Investment Income stood at $143000.0 in 2022, then sank by 46.85% to $76000.0 in 2023, then slumped by 65.79% to $26000.0 in 2024, then soared by 253.85% to $92000.0 in 2025, then plunged by 60.87% to $36000.0 in 2026.
- Business Quant data shows VIVS's Interest & Investment Income at $36000.0 in Q1 2026, $92000.0 in Q3 2025, and $76000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | 28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Sep 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 406,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 157,000.00 |
| Mar 31, 2023 | 451,000.00 |
| Dec 31, 2022 | 143,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |